Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung CancerG. Frasci, Mario De Lena, Vito Lorusso et al.|Journal of Clinical Oncology|2000Cited by 452
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancerLucio Crinò, Angelo Delmonte, Antonio Frassoldati et al.|Lung Cancer|2019Cited by 158
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS MetastasesDiego Cortinovis, Angelo Delmonte, Rita Chiari et al.|Anticancer Research|2019Cited by 38
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trialsMassimo Di Maïo, Cesare Gridelli, Simona Signoriello et al.|Lung Cancer|2012Cited by 22
Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trialP. Comella, G. Comella, G. Frasci et al.|Lung Cancer|2000Cited by 16